Canada markets closed

Glenmark Pharmaceuticals Limited (GLENMARK.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
1,230.65+9.50 (+0.78%)
At close: 03:29PM IST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
116,354,560
116,354,560
114,319,380
121,741,980
108,060,260
-
Cost of Revenue
44,133,700
44,133,700
42,575,360
47,781,710
39,966,250
-
Gross Profit
72,220,860
72,220,860
71,744,020
73,960,270
68,094,010
-
Operating Expenses
Selling General and Administrative
-
-
14,581,030
12,970,030
12,604,780
13,706,970
Total Operating Expenses
66,086,610
66,086,610
61,085,710
55,559,790
50,933,650
-
Operating Income or Loss
6,134,250
6,134,250
10,658,310
18,400,480
17,160,360
-
Interest Expense
5,159,690
5,159,690
3,490,360
2,980,990
3,531,130
-
Income Before Tax
364,950
364,950
2,398,420
14,412,460
13,824,750
-
Income Tax Expense
18,673,450
18,673,450
3,294,030
4,475,970
4,123,870
-
Income from Continuing Operations
-18,308,500
-18,308,500
-895,610
9,936,490
9,700,880
-
Net Income
-15,016,680
-15,016,680
2,972,450
9,417,110
9,700,380
-
Net Income available to common shareholders
-15,016,680
-15,016,680
2,972,450
9,417,110
9,700,380
-
Basic EPS
-3.11
-
10.53
33.37
34.38
27.50
Diluted EPS
-3.11
-
10.53
33.37
34.38
27.50
Basic Average Shares
282,112
-
282,284
282,168
282,168
282,168
Diluted Average Shares
282,112
-
282,284
282,168
282,168
282,168